Managing Immune Checkpoint-Blocking Antibody Side Effects
Immune checkpoint-blocking antibodies that enhance the immune system's ability to fight cancer are becoming important components of treatment for patients with a variety of malignancies. Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) was the first immune checkpoint to be clinically target...
Saved in:
| Main Author: | |
|---|---|
| Format: | Revisão |
| Language: | English |
| Published: |
2015
|
| Online Access: | https://doi.org/10.14694/edbook_am.2015.35.76 https://ascopubs.org/doi/pdfdirect/10.14694/EdBook_AM.2015.35.76 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!